Magnesium citrate In a study of 40 patients with migraine without aura, oral magnesium citrate (600 mg daily) decreased the frequency of attacks by 33% and severity of attacks by 47% (Koseoglu 2008)
Extended Use Studies Research examining prolonged aod 9604 peptide administration has provided valuable insights into long-term safety profiles: Tolerance Development : Some studies suggest that individuals may develop tolerance to certain side effects over time, particularly mild injection site reactions and initial fatigue
However, some researchers apply small amounts of reconstituted GHK-Cu topically to targeted areas
del Rincon J-P, Iida K, Gaylinn BD, McCurdy CE, Leitner JW, Barbour LA, Kopchick JJ, Friedman JE, Draznin B, Thorner MO